Origin of personalized medicine in pioneering, passionate, genomic research

Personalized medicine, one of the main promises of the Human Genome Project (HGP) that began three decades ago, is now a new therapeutic paradigm. With its arrival the era of developing drugs to suit all patients, yet often having to withdraw a promising new one because a minority of patients was...

Descripción completa

Detalles Bibliográficos
Autor principal: Barrera Saldaña, Hugo Alberto
Formato: Artículo
Lenguaje:inglés
Publicado: 2020
Materias:
Acceso en línea:http://eprints.uanl.mx/20119/1/1-s2.0-S0888754319300692-main.pdf
_version_ 1824415756015632384
author Barrera Saldaña, Hugo Alberto
author_facet Barrera Saldaña, Hugo Alberto
author_sort Barrera Saldaña, Hugo Alberto
collection Repositorio Institucional
description Personalized medicine, one of the main promises of the Human Genome Project (HGP) that began three decades ago, is now a new therapeutic paradigm. With its arrival the era of developing drugs to suit all patients, yet often having to withdraw a promising new one because a minority of patients was at risk, even though it had proved valuable for the majority was consigned to history as were trial-and-error strategies being the predominant means of tailoring therapy. But how did it originate and the earliest examples emerge? Is it true that the first personalized diagnostic test was the companion test for Herceptin®? This account of a remarkable journey from genomic and translational research to therapeutic and diagnostic innovations, describes how sequencing the human growth hormone (hGH) locus provided proof of principle for HGP-inspired personalized medicine. Sequencing this locus and the resultant biomanufacture of HGH and the development of a test capable of detecting which patients would benefit from its administration helped silence the skeptics who questioned the validity of such an approach. The associated companion diagnostic was created four years before the invention of the HercepTest® (registered as the first companion diagnostics ever developed). By cultivating genomic research with passion and pursuing its applications, we and many others contributed to the emergence of a new diagnostics industry, the discovery of better actionable gene-targets and to a revitalized pharmaceutical industry capable of developing safer and more effective therapies. In combination, these developments are beginning to fulfill the promise of the HGP, offering each patient the opportunity to adopt the right treatment at the correct dosage in an opportune manner.
format Article
id eprints-20119
institution UANL
language English
publishDate 2020
record_format eprints
spelling eprints-201192024-12-09T17:43:20Z http://eprints.uanl.mx/20119/ Origin of personalized medicine in pioneering, passionate, genomic research Barrera Saldaña, Hugo Alberto QH Historia Natural, Biología Personalized medicine, one of the main promises of the Human Genome Project (HGP) that began three decades ago, is now a new therapeutic paradigm. With its arrival the era of developing drugs to suit all patients, yet often having to withdraw a promising new one because a minority of patients was at risk, even though it had proved valuable for the majority was consigned to history as were trial-and-error strategies being the predominant means of tailoring therapy. But how did it originate and the earliest examples emerge? Is it true that the first personalized diagnostic test was the companion test for Herceptin®? This account of a remarkable journey from genomic and translational research to therapeutic and diagnostic innovations, describes how sequencing the human growth hormone (hGH) locus provided proof of principle for HGP-inspired personalized medicine. Sequencing this locus and the resultant biomanufacture of HGH and the development of a test capable of detecting which patients would benefit from its administration helped silence the skeptics who questioned the validity of such an approach. The associated companion diagnostic was created four years before the invention of the HercepTest® (registered as the first companion diagnostics ever developed). By cultivating genomic research with passion and pursuing its applications, we and many others contributed to the emergence of a new diagnostics industry, the discovery of better actionable gene-targets and to a revitalized pharmaceutical industry capable of developing safer and more effective therapies. In combination, these developments are beginning to fulfill the promise of the HGP, offering each patient the opportunity to adopt the right treatment at the correct dosage in an opportune manner. 2020 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/20119/1/1-s2.0-S0888754319300692-main.pdf http://eprints.uanl.mx/20119/1.haspreviewThumbnailVersion/1-s2.0-S0888754319300692-main.pdf Barrera Saldaña, Hugo Alberto (2020) Origin of personalized medicine in pioneering, passionate, genomic research. Genomics, 112 (1). pp. 721-728. ISSN 0888-7543 http://doi.org/10.1016/J.YGENO.2019.05.006 doi:10.1016/J.YGENO.2019.05.006
spellingShingle QH Historia Natural, Biología
Barrera Saldaña, Hugo Alberto
Origin of personalized medicine in pioneering, passionate, genomic research
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Origin of personalized medicine in pioneering, passionate, genomic research
title_full Origin of personalized medicine in pioneering, passionate, genomic research
title_fullStr Origin of personalized medicine in pioneering, passionate, genomic research
title_full_unstemmed Origin of personalized medicine in pioneering, passionate, genomic research
title_short Origin of personalized medicine in pioneering, passionate, genomic research
title_sort origin of personalized medicine in pioneering passionate genomic research
topic QH Historia Natural, Biología
url http://eprints.uanl.mx/20119/1/1-s2.0-S0888754319300692-main.pdf
work_keys_str_mv AT barrerasaldanahugoalberto originofpersonalizedmedicineinpioneeringpassionategenomicresearch